Oncology Clinical Development Congress - United Kingdom

Over 120 Oncology Clinical Trials, Clinical Development, Diagnostics Development, and Translational Research experts from Europe, US and Asia

Over 60 outstanding case studies and presentations

2 day conference covering key insights into Cancer Clinical Trials and Personalized Medicine, Companion Diagnostics Development as well as successful development, design and analysis of clinical trials

Interactive exhibition room for networking activities and one-to-one meetings

Oxford Global is proud to present the Oncology Clinical Development Congress to be held on the 10th -11th October 2012, Manchester. It is to be co-located with our 2nd Annual Oncology Biomarker Congress.

Over the 2 days, the event provides a first class educational and networking opportunity for over 120 attendees to gain knowledge and insights into the Oncology Clinical Development market. The event will bring together key scientists and investigators in oncology clinical trials, clinical R&D, adaptive trials, oncology diagnostics development, and translational research from leading pharmaceutical, biotechnology, diagnostics, clinical research companies and academic institutions in the UK and Europe.

The programme feature topics on improving safety & risk assessment in Oncology clinical trials and clinical development by implementing biomarkers, manage patient selection & recruitment and identify potential cost savings through successful integration of companion diagnostics and enabling technologies in clinical development. Do not miss out on the opportunity to learn insights on effective development, design and analysis of clinical trials.

This prestigious event provides a forum for practitioners and researchers to learn more about key solutions being provided to their industry, analysis of current technologies and their applications, network with their peers and address key industry concerns through a series of cutting edge conference presentations and interactive exhibition room in a professional yet relaxed environment.

More about the Event

Read More

40th Congress of the International Society of Oncology and Biomarkers (ISOBM)

The 40th ISOBM Anniversary Congress will take place in Jerusalem, Israel,

October 13- 17, 2012.

On behalf of the ISOBM Board and the Organizing Committee of our 40th ISOBM Anniversary Congress, we are pleased to invite you to participate actively at this Congress.


We anticipate a highly successful and exciting Congress focusing on basic, translational and clinical Cancer Research. Participants will have the opportunity to present and discuss their data, exchange ideas and expertise in an international framework, meet and network with colleagues from around the world and listen to lectures delivered by prominent Opinion Leaders in the Cancer field.

With your participation, contribution and activity, we hope to cover the full range of innovations in Cancer Diagnostics, BioMarkers and Cancer Therapy (new approaches as Small Molecules, Therapeutic Antibodies, Immuno-therapeutics, Large Biomolecules, etc.), to facilitate discussion and collaboration between early stage companies that are developing innovative products and technologies – all will contribute to a most successful meeting.

We will offer most interesting presentations by Invited Opinion Leaders, as well as Oral Presentations or Poster Sessions to be selected from the submitted Abstracts, Clinical Workshops and Round Tables.

The congress city, Jerusalem, situated high in the Judean Hills, is one of the most extraordinary cities in the world, established 3000 years ago by King David.
Jerusalem presents a unique combination of ancient history, spiritual sanctity and colorful cultures. Jerusalem is a fascinating city of many contrasts and diversities. It is a city where old and new, holy and secular, pure nature and beautiful architecture mix into magical harmony of smells, sounds and sights.
Sacred to the world's three main monotheistic religions, Jerusalem is a captivating city, whose visitors are left touched and inspired by the shining glow of its religious shrines of Judaism, Christianity and Islam, picturesque scenery and magnificent golden limestone.
Jerusalem is also the Capital of Israel, home to the Israeli Parliament (Knesset), the President's Residence and the Government offices.

We hope that you will be able to accept our invitation and participate in what promises to be a most important and stimulating Congress, as well as a memorable visit to Jerusalem- a truly worthwhile experience.


Read more about Oncology by www.isobm-conference.org

Read More

40th Congress of the International Society of Oncology and Biomarkers (ISOBM)

The 40th ISOBM Anniversary Congress will take place in Jerusalem, Israel,

October 13- 17, 2012.

On behalf of the ISOBM Board and the Organizing Committee of our 40th ISOBM Anniversary Congress, we are pleased to invite you to participate actively at this Congress.


We anticipate a highly successful and exciting Congress focusing on basic, translational and clinical Cancer Research. Participants will have the opportunity to present and discuss their data, exchange ideas and expertise in an international framework, meet and network with colleagues from around the world and listen to lectures delivered by prominent Opinion Leaders in the Cancer field.

With your participation, contribution and activity, we hope to cover the full range of innovations in Cancer Diagnostics, BioMarkers and Cancer Therapy (new approaches as Small Molecules, Therapeutic Antibodies, Immuno-therapeutics, Large Biomolecules, etc.), to facilitate discussion and collaboration between early stage companies that are developing innovative products and technologies – all will contribute to a most successful meeting.

We will offer most interesting presentations by Invited Opinion Leaders, as well as Oral Presentations or Poster Sessions to be selected from the submitted Abstracts, Clinical Workshops and Round Tables.

The congress city, Jerusalem, situated high in the Judean Hills, is one of the most extraordinary cities in the world, established 3000 years ago by King David.
Jerusalem presents a unique combination of ancient history, spiritual sanctity and colorful cultures. Jerusalem is a fascinating city of many contrasts and diversities. It is a city where old and new, holy and secular, pure nature and beautiful architecture mix into magical harmony of smells, sounds and sights.
Sacred to the world's three main monotheistic religions, Jerusalem is a captivating city, whose visitors are left touched and inspired by the shining glow of its religious shrines of Judaism, Christianity and Islam, picturesque scenery and magnificent golden limestone.
Jerusalem is also the Capital of Israel, home to the Israeli Parliament (Knesset), the President's Residence and the Government offices.

We hope that you will be able to accept our invitation and participate in what promises to be a most important and stimulating Congress, as well as a memorable visit to Jerusalem- a truly worthwhile experience.


Further details and to register

Read More

Oncology Clinical Development Congress 2012 - United Kingdom

Over 120 Oncology Clinical Trials, Clinical Development, Diagnostics Development, and Translational Research experts from Europe, US and Asia

Over 60 outstanding case studies and presentations

2 day conference covering key insights into Cancer Clinical Trials and Personalized Medicine, Companion Diagnostics Development as well as successful development, design and analysis of clinical trials

Interactive exhibition room for networking activities and one-to-one meetings

Oxford Global is proud to present the Oncology Clinical Development Congress to be held on the 10th -11th October 2012, Manchester. It is to be co-located with our 2nd Annual Oncology Biomarker Congress.

Over the 2 days, the event provides a first class educational and networking opportunity for over 120 attendees to gain knowledge and insights into the Oncology Clinical Development market. The event will bring together key scientists and investigators in oncology clinical trials, clinical R&D, adaptive trials, oncology diagnostics development, and translational research from leading pharmaceutical, biotechnology, diagnostics, clinical research companies and academic institutions in the UK and Europe.

The programme feature topics on improving safety & risk assessment in Oncology clinical trials and clinical development by implementing biomarkers, manage patient selection & recruitment and identify potential cost savings through successful integration of companion diagnostics and enabling technologies in clinical development. Do not miss out on the opportunity to learn insights on effective development, design and analysis of clinical trials.

This prestigious event provides a forum for practitioners and researchers to learn more about key solutions being provided to their industry, analysis of current technologies and their applications, network with their peers and address key industry concerns through a series of cutting edge conference presentations and interactive exhibition room in a professional yet relaxed environment.

Further details and to register

Read More

USA 2012: Molecular Diagnostics World Congress and Exhibition

This conference will discuss;
* Oncology Biomarkers,
* Companion Diagnostics,
* Cancer Personalised Medicine,
* MDx for Infectious Diseases,
* Next-Generation Sequencing,
* Emerging technologies in MDx
* Emerging Classes of Biomarkers for MDx.

The conference will be co-located with Microarray World Congress, Lab-on-a-Chip World Congress and Single Cell Analysis Summit. Registered delegates will have access to all four meetings ensuring a very cost-effective trip.

Further details and to register

Read More

BITs 5th Anniversary of World Cancer Congress (WCC-2012)

BIT Congress is proud to launch the 5th Anniversary of World Cancer Congress (WCC), which will be held from May 18 to May 20, 2012 in Beijing, China (http://www.bitlifesciences.com/cancer2012/ ).
The congress theme of this year is "Hand-in-Hand for Caring" in keeping with the rapid growth and results in cancer research and care throughout the world. The 3-day diverse program has been designed to cover the breadth of oncology from cancer epidemiology and prevention, from drug discovery to cancer treatment and palliative care. It will also cover the main oncological aspects of these themes from molecular biology and genetics, to targeted therapies, innovation technology radiotherapy and imaging.

The program is a very interesting mix of plenary lectures, the technical sessions, educational training courses, practical clinical case as well as industry supported symposia will provide delegates with information on the latest developments in basic science and clinical treatment. Several workshops and posters / papers session will be held concurrently to allow sharing of the excellent experience. The high profile speakers will provide productive form to greatly refresh the participant's knowledge and experience. Participants will enhance practical knowledge for everyday use and explore the most up-to-date information regarding the treatment of cancer.

Please seize this wonderful opportunity and feel free to participate actively in all areas of the conference, I feel confident that you will enjoy both of the scientific program and the fine, traditional city of Beijing.

Further Event Details

Read More

Czech Republic: Natural Anticancer Drugs conference

Natural Anticancer Drugs (NAD2012) will be held from June 30 to July 4, 2012, in Olomouc, Czech Republic. NAD will attempt to inform about the most current topics in natural anticancer drug research, including drug discovery, production of natural compounds, molecular targets and mechanisms, chemoprevention, and successful stories. Invited keynote speakers will give plenary lectures on the hot topics covering a broad range of research areas related to natural compounds. NAD is aimed at the whole scientific community including students, academics, and industry researchers who are interested in the fundamental mechanisms underlying anticancer activity of natural compounds. Further Conference Details

Read More

Healthcare Centers of Excellence Summit 2012, USA

Healthcare providers are facing increasingly difficult challenges. Major Regulatory initiatives laced with uncertainty, lower reimbursement levels, higher numbers of uninsured patients (and under insured), rising costs and continued scrutiny must be successfully navigated by hospital executives and administrators while ensuring quality patient experiences.

Only those armed with the best knowledge, strategic and tactical insight, and the keen understanding that healthcare administrators must continually innovate will avoid being left behind and achieve success. This begins with a strong network of colleagues and learning from those with exceptional inside knowledge.

The Healthcare Centers of Excellence Summit will assemble a faculty offering high level, detailed insight based on real-world knowledge. The issues you face each day will be examined with solutions & results explained in interactive discussions all while relationships with colleagues are developed. Experts from various backgrounds, perspectives, positions and specialties will come together allowing a 360° viewpoint of the business and administrative challenges in managing a healthcare center.

Uniquely focusing on specialty departments while simultaneously offering cross departmental learning and networking opportunities, the Summit has three distinctive conference tracks:
1) Cardiac Centers of Excellence
2) Cancer Centers of Excellence
3) Diabetes Centers of Excellence

Whether a delegate chooses to concentrate on a specific track or attend portions of all three, an unparalleled ability to learn, network and share professional insights will be provided.

Conference Website

Read More

5th Latin American Conference on Lung Cancer - Brazil

On behalf of the International Association for the Study of Lung Cancer (IASLC) and the Local Organizing Committee, it is a great pleasure and an honor to extend to you a warm invitation to attend the 5th Latin American Conference on Lung Cancer (LALCA 2012) to be held July 25 through July 27, 2012 in Rio de Janeiro, Brazil.

Lung Cancer is still the leading cause of death not only in Latin America but worldwide. Building on the success of the previous conference in 2010 in Buenos Aires, Argentina, international and national speakers will discuss the science and advances in the treatment and prevention of lung cancer.

With tobacco being the leading cause of morbi-mortality worldwide and it’s consumption leading to respiratory and cardiovascular disease, as well as cancer, causing the loss of 800,000 otherwise healthy Brazilian lives every year, the Conference would like to support the Framework Convention for Tobacco Control and will again host a Tobacco Forum on Wednesday, July 25.

The Scientific Program will feature basic and translational research, molecular diagnosis and prognostic factors, early diagnosis, targeted and individualized therapies, surgical and clinical management of lung cancer including radiotherapy and supportive care.

Abstract Submission Deadline           March 30, 2012

 25 to 27 July 2012 Rio de Janeiro, Brazil

Further Information

Read More

Cancer Research Global Summit United Kingdom

Cancer Research Global Summit: The Future of Cancer Therapeutics: Accelerating Progress at the Molecular Level
2011 August 16 - August 17 / London, UNITED KINGDOM

Join your peers and colleagues at the Cancer Research Conference event London UK.
The objective of this conference is to provide communication, education and networking opportunities for scientists engaged in Cancer Research and Development whether in academia, biotech or industry.

Read More